Gregorc, V.; Lazzari, C.; Mandalá, M.; Ippati, S.; Bulotta, A.; Cangi, M.G.; Khater, A.; Viganò, M.G.; Mirabile, A.; Pecciarini, L.;
et al. Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer. Cancers 2021, 13, 2023.
https://doi.org/10.3390/cancers13092023
AMA Style
Gregorc V, Lazzari C, Mandalá M, Ippati S, Bulotta A, Cangi MG, Khater A, Viganò MG, Mirabile A, Pecciarini L,
et al. Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer. Cancers. 2021; 13(9):2023.
https://doi.org/10.3390/cancers13092023
Chicago/Turabian Style
Gregorc, Vanesa, Chiara Lazzari, Mario Mandalá, Stefania Ippati, Alessandra Bulotta, Maria Giulia Cangi, Abdelrahman Khater, Maria Grazia Viganò, Aurora Mirabile, Lorenza Pecciarini,
and et al. 2021. "Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer" Cancers 13, no. 9: 2023.
https://doi.org/10.3390/cancers13092023
APA Style
Gregorc, V., Lazzari, C., Mandalá, M., Ippati, S., Bulotta, A., Cangi, M. G., Khater, A., Viganò, M. G., Mirabile, A., Pecciarini, L., Ogliari, F. R., Arrigoni, G., Grassini, G., Veronesi, G., & Doglioni, C.
(2021). Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer. Cancers, 13(9), 2023.
https://doi.org/10.3390/cancers13092023
